<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Kaspar Rufibach on Kaspar Rufibach</title>
    <link>https://numbersman77.netlify.com/</link>
    <description>Recent content in Kaspar Rufibach on Kaspar Rufibach</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>&amp;copy; 2019</copyright>
    <lastBuildDate>Mon, 01 Jul 2019 00:00:00 +0000</lastBuildDate>
    <atom:link href="/" rel="self" type="application/rss+xml" />
    
    <item>
      <title>Advanced methods for group-sequential trials</title>
      <link>https://numbersman77.netlify.com/teaching/201907_groupseq/</link>
      <pubDate>Mon, 01 Jul 2019 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/teaching/201907_groupseq/</guid>
      <description>&lt;p&gt;Half-day pre-conference course at &lt;a href=&#34;https://kuleuvencongres.be/iscb40&#34; target=&#34;_blank&#34;&gt;ISCB40&lt;/a&gt; in Leuven. Details on the program are available &lt;a href=&#34;https://kuleuvencongres.be/iscb40/selected-course-descriptions.pdf&#34; target=&#34;_blank&#34;&gt;here&lt;/a&gt;.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Advanced methods for group-sequential trials</title>
      <link>https://numbersman77.netlify.com/teaching/201903_groupseq/</link>
      <pubDate>Fri, 01 Mar 2019 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/teaching/201903_groupseq/</guid>
      <description>&lt;p&gt;Half-day course for Roche statisticians in Basel.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Integrating Phase 2 into Phase 3 based on an Intermediate Endpoint While Accounting for a Cure Proportion</title>
      <link>https://numbersman77.netlify.com/publication/stats_articles/2019_04_mirros/</link>
      <pubDate>Fri, 04 Jan 2019 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/publication/stats_articles/2019_04_mirros/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Joint modelling of progression-free and overall survival and computation of correlation measures</title>
      <link>https://numbersman77.netlify.com/publication/stats_articles/2019_03_pfs_os/</link>
      <pubDate>Thu, 03 Jan 2019 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/publication/stats_articles/2019_03_pfs_os/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A multistate model for early decision making in oncology</title>
      <link>https://numbersman77.netlify.com/publication/stats_articles/2019_02_multiearly/</link>
      <pubDate>Wed, 02 Jan 2019 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/publication/stats_articles/2019_02_multiearly/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Treatment Effect Quantification for Time-to-event Endpoints - Estimands, Analysis Strategies, and beyond</title>
      <link>https://numbersman77.netlify.com/publication/stats_articles/2019_01_estimand_t2e/</link>
      <pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/publication/stats_articles/2019_01_estimand_t2e/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Group-sequential and adaptive clinical trial designs, with R practicals</title>
      <link>https://numbersman77.netlify.com/teaching/201803_groupseq/</link>
      <pubDate>Thu, 01 Mar 2018 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/teaching/201803_groupseq/</guid>
      <description>&lt;p&gt;Full-day course organized by the &lt;a href=&#34;http://bbs.ceb-institute.org&#34; target=&#34;_blank&#34;&gt;Basel Biometric Section&lt;/a&gt;.&lt;br&gt;&lt;/p&gt;

&lt;p&gt;&lt;a href=&#34;http://bbs.ceb-institute.org/?p=1118&#34; target=&#34;_blank&#34;&gt;Announcement&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title></title>
      <link>https://numbersman77.netlify.com/talk/1900_template/</link>
      <pubDate>Thu, 11 Jan 2018 00:00:00 +0100</pubDate>
      
      <guid>https://numbersman77.netlify.com/talk/1900_template/</guid>
      <description>&lt;!-- Embed your slides or video here using [shortcodes](https://sourcethemes.com/academic/post/writing-markdown-latex/). Further details can easily be added using *Markdown* and $\rm \LaTeX$ math code. --&gt;
</description>
    </item>
    
    <item>
      <title>Before going BIG - seize opportunities for small data: use of multistate models to improve decision-making and effect quantification in clinical trials</title>
      <link>https://numbersman77.netlify.com/talk/2019_roes/</link>
      <pubDate>Thu, 11 Jan 2018 00:00:00 +0100</pubDate>
      
      <guid>https://numbersman77.netlify.com/talk/2019_roes/</guid>
      <description>&lt;!-- Embed your slides or video here using [shortcodes](https://sourcethemes.com/academic/post/writing-markdown-latex/). Further details can easily be added using *Markdown* and $\rm \LaTeX$ math code. --&gt;
</description>
    </item>
    
    <item>
      <title>Implications of the ICH E9 estimand addendum on how we develop, run, and analyze clinical trials</title>
      <link>https://numbersman77.netlify.com/talk/2019_ct_europe/</link>
      <pubDate>Thu, 11 Jan 2018 00:00:00 +0100</pubDate>
      
      <guid>https://numbersman77.netlify.com/talk/2019_ct_europe/</guid>
      <description>&lt;!-- Embed your slides or video here using [shortcodes](https://sourcethemes.com/academic/post/writing-markdown-latex/). Further details can easily be added using *Markdown* and $\rm \LaTeX$ math code. --&gt;
</description>
    </item>
    
    <item>
      <title>rpact - R Package for Adaptive Clinical Trials</title>
      <link>https://numbersman77.netlify.com/talk/2019_psi_webinar/</link>
      <pubDate>Thu, 11 Jan 2018 00:00:00 +0100</pubDate>
      
      <guid>https://numbersman77.netlify.com/talk/2019_psi_webinar/</guid>
      <description>&lt;!-- Embed your slides or video here using [shortcodes](https://sourcethemes.com/academic/post/writing-markdown-latex/). Further details can easily be added using *Markdown* and $\rm \LaTeX$ math code. --&gt;
</description>
    </item>
    
    <item>
      <title>Comparison of different clinical development plans for confirmatory subpopulation selection</title>
      <link>https://numbersman77.netlify.com/publication/stats_articles/2016_02_cdp_subpop/</link>
      <pubDate>Sat, 02 Jan 2016 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/publication/stats_articles/2016_02_cdp_subpop/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Bayesian Predictive Power: Choice of Prior and some Recommendations for its Use as Probability of Success in Drug Development</title>
      <link>https://numbersman77.netlify.com/publication/stats_articles/2016_04_ptsbathtub/</link>
      <pubDate>Fri, 01 Jan 2016 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/publication/stats_articles/2016_04_ptsbathtub/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Sequentially Updating the Likelihood of Success of a Phase 3 Pivotal Time-to-Event Trial based on Interim Analyses or External Information</title>
      <link>https://numbersman77.netlify.com/publication/stats_articles/2016_01_ptsupdate/</link>
      <pubDate>Fri, 01 Jan 2016 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/publication/stats_articles/2016_01_ptsupdate/</guid>
      <description></description>
    </item>
    
    <item>
      <title>bpp</title>
      <link>https://numbersman77.netlify.com/software/bpp/</link>
      <pubDate>Fri, 01 Jan 2016 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/software/bpp/</guid>
      <description>&lt;p&gt;Implements functions to update Bayesian Predictive Power Computations after not stopping a clinical trial at an interim analysis. Such an interim analysis can either be blinded or unblinded. Code is provided for Normally distributed endpoints with known variance, with a prominent example being the hazard ratio.&lt;/p&gt;

&lt;p&gt;&lt;a href=&#34;http://cran.r-project.org/package=bpp&#34; target=&#34;_blank&#34;&gt;Download bpp from CRAN&lt;/a&gt;&lt;br&gt;
&lt;a href=&#34;http://dx.doi.org/10.1080/10543406.2014.972508&#34; target=&#34;_blank&#34;&gt;Paper 1&lt;/a&gt;&lt;br&gt;
&lt;a href=&#34;http://dx.doi.org/10.1002/pst.1764&#34; target=&#34;_blank&#34;&gt;Paper 2&lt;/a&gt;&lt;br&gt;&lt;/p&gt;

&lt;p&gt;&lt;img src=&#34;https://cranlogs.r-pkg.org/badges/bpp&#34; alt=&#34;&#34; /&gt;&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
